Harriet M. Bryson
- Pharmacology top 0.5%
- Epidemiology top 5%
- Molecular Medicine top 0.5%
- Molecular Biology
- Physiology top 10%
- Co-authors
- Antona J. WagstaffRick DavisBret FultonDiana FauldsRex N. BrogdenJulia A. BalfourPaul BenfieldAnthony Markham
- Topics
- Antibiotics Pharmacokinetics and Efficacy (12 papers)Antibiotic Resistance in Bacteria (10 papers)Pneumonia and Respiratory Infections (4 papers)
- Journals
- DrugsCNS DrugsPharmacoEconomics
- Partner nations
- New Zealand
In The Last Decade
Harriet M. Bryson
49 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 136
- Pharmacology 1.0k
- Epidemiology 893
- Molecular Medicine 520
- Molecular Biology 496
- Physiology 364
Countries citing papers authored by Harriet M. Bryson
This map shows the geographic impact of Harriet M. Bryson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet M. Bryson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet M. Bryson more than expected).
Fields of papers citing papers by Harriet M. Bryson
This network shows the impact of papers produced by Harriet M. Bryson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet M. Bryson. The network helps show where Harriet M. Bryson may publish in the future.
Co-authorship network of co-authors of Harriet M. Bryson
This figure shows the co-authorship network connecting the top 25 collaborators of Harriet M. Bryson. A scholar is included among the top collaborators of Harriet M. Bryson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harriet M. Bryson. Harriet M. Bryson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | 117 | |
| 3 | 109 | |
| 4 | 159 | |
| 5 | 206 | |
| 6 | 62 | |
| 7 | 26 | |
| 8 | 38 | |
| 9 | 166 | |
| 10 | 20 | |
| 11 | 147 | |
| 12 | 66 | |
| 13 | 93 | |
| 14 | 89 | |
| 15 | 28 | |
| 16 | 135 | |
| 17 | 10 | |
| 18 | 27 | |
| 19 | 83 | |
| 20 | 70 |
About Harriet M. Bryson
Harriet M. Bryson is a scholar working on Molecular Medicine, Pharmacology and Anesthesiology and Pain Medicine, having authored 49 papers that have together received 3.8k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Molecular Medicine (520 citations), Applied Microbiology and Biotechnology (147 citations) and Pharmacology (1.0k citations). Harriet M. Bryson has collaborated with scholars based in New Zealand. Frequent co-authors include Antona J. Wagstaff, Rick Davis, Bret Fulton, Diana Faulds, Rex N. Brogden, Julia A. Balfour, Paul Benfield, Anthony Markham, Karen L. Goa and Michelle I. Wilde. Their work appears in journals such as Drugs, CNS Drugs and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.